The data obtained in this study from the screening and validation experiments confirmed that PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 may have, or provide support for, potential tumor suppression roles in breast cancer. This evidence concerns the gene MAGI2 and breast carcinoma.